SP2-4 Impact of COVID-19 on clinical practice and research in oncology in Singapore – experience of the National University Cancer Institute

por Soo, Ross A.
Publicado 2021

Nivolumab in the treatment of metastatic squamous non-small cell lung cancer: a review of the evidence

por Lim, Joline S. J., Soo, Ross A.
Publicado 2016

Resistance to immune checkpoint inhibitors in non-small cell lung cancer: biomarkers and therapeutic strategies

por Walsh, Robert J., Soo, Ross A.
Publicado 2020

Dacomitinib in lung cancer: a “lost generation” EGFR tyrosine-kinase inhibitor from a bygone era?

por Ou, Sai-Hong Ignatius, Soo, Ross A
Publicado 2015

Profile of nivolumab in the treatment of metastatic squamous non-small-cell lung cancer

por Ang, Yvonne LE, Lim, Joline SJ, Soo, Ross A
Publicado 2016

A meta-analysis on immune checkpoint inhibitor efficacy for advanced non-small cell lung cancer between East Asians versus non-East Asians

por Peng, Siyu, Ying, Ariel Fangting, Tai, Bee Choo, Soo, Ross Andrew
Publicado 2020

The Role of Monoclonal Antibody in Combination with First-Line Chemotherapy in Asian Patients with Advanced Non-Small Cell Lung Cancer

por Cho, Byoung Chul, Kim, Joo Hang, Soo, Ross A, Yang, Chih-Hsin
Publicado 2010

Resectable non-small cell lung cancer: an evolving landscape

por Loh, Jerold, Wijaya, Silvana T, Sooi, Kenneth, Chia, Puey Ling, Soo, Ross A.
Publicado 2022

Combatting acquired resistance to osimertinib in EGFR-mutant lung cancer

por Lee, Jiyun, Piotrowska, Zofia, Soo, Ross, Cho, Byoung Chul, Lim, Sun Min
Publicado 2022

The evolving immuno-oncology landscape in advanced lung cancer: first-line treatment of non-small cell lung cancer

por Low, Jia Li, Walsh, Robert J., Ang, Yvonne, Chan, Gloria, Soo, Ross A.
Publicado 2019

Different treatment efficacies and side effects of cytotoxic chemotherapy

por Li, Low-Jia, Chong, Qingyun, Wang, Lingzhi, Cher, Goh Boon, Soo, Ross A.
Publicado 2020

Will the Requirement by the US FDA to Simultaneously Co-Develop Companion Diagnostics (CDx) Delay the Approval of Receptor Tyrosine Kinase Inhibitors for RTK-Rearranged (ROS1-, RET...

por Ou, Sai-Hong Ignatius, Soo, Ross A., Kubo, Akihito, Kawaguchi, Tomoya, Ahn, Myung-Ju
Publicado 2014

How to select the best upfront therapy for metastatic disease? Focus on ALK-rearranged non-small cell lung cancer (NSCLC)

por Xia, Bing, Nagasaka, Misako, Zhu, Viola W., Ou, Sai-Hong Ignatius, Soo, Ross A.
Publicado 2020

Advances in the management of non-small-cell lung cancer harbouring EGFR exon 20 insertion mutations

por Low, Jia Li, Lim, Sun Min, Lee, Jii Bum, Cho, Byoung Chul, Soo, Ross A
Publicado 2023

Prognostic significance of immune cells in non-small cell lung cancer: meta-analysis

por Soo, Ross A., Chen, Zhaojin, Yan Teng, Rebecca Siew, Tan, Hon-Lyn, Iacopetta, Barry, Tai, Bee Choo, Soong, Richie
Publicado 2018

EGFR kinase inhibitors and gastric acid suppressants in EGFR-mutant NSCLC: a retrospective database analysis of potential drug interaction

por Kumarakulasinghe, Nesaretnam Barr, Syn, Nicholas, Soon, Yu Yang, Asmat, Atasha, Zheng, Huili, Loy, En Yun, Pang, Brendan, Soo, Ross Andrew
Publicado 2016

Treatment Patterns in Patients with Locally Advanced or Metastatic Non-Small-Cell Lung Cancer Treated with Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors: Analysis of...

por Soo, Ross A., Seto, Takashi, Gray, Jhanelle E., Thiel, Ellen, Taylor, Aliki, Sawyer, William, Karimi, Parisa, Marchlewicz, Elizabeth, Brouillette, Matthew
Publicado 2021

INSPIRE: A phase III study of the BLP25 liposome vaccine (L-BLP25) in Asian patients with unresectable stage III non-small cell lung cancer

por Wu, Yi-Long, Park, Keunchil, Soo, Ross A, Sun, Yan, Tyroller, Karin, Wages, David, Ely, Guy, Yang, James Chih-Hsin, Mok, Tony
Publicado 2011

Real-world global data on targeting epidermal growth factor receptor mutations in stage III non-small-cell lung cancer: the results of the KINDLE study

por Jazieh, Abdul Rahman, Onal, Huseyin Cem, Tan, Daniel Shao-Weng, Soo, Ross A., Prabhash, Kumar, Kumar, Amit, Huggenberger, Reto, Cho, Byoung Chul
Publicado 2022

Third generation EGFR TKIs: current data and future directions

por Tan, Chee-Seng, Kumarakulasinghe, Nesaretnam Barr, Huang, Yi-Qing, Ang, Yvonne Li En, Choo, Joan Rou-En, Goh, Boon-Cher, Soo, Ross A.
Publicado 2018